Biotech is big, and the industry has been big for quite some time.
As a matter of fact, biotechnology has been the second-best performing industry over the last two years.
Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.
However, at the end of the day, the big biotechs are the ones that make the headlines.
Related Link: Celgene Sells Off, But Begins Move Back Up
Below is a list of the five biggest biotech stocks by market capitalization.
The biotech stock with the fifth-largest market cap is Regeneron Pharmaceuticals Inc (NASDAQ: REGN).
At time of writing, Regeneron’s market cap sat just over $41 billion.
The fourth-largest biotech stock is Biogen Idec Inc (NASDAQ: BIIB).
Biogen’s market cap is more than double that of Regeneron at above $83 billion.
Coming in as the third-biggest biotech stock on the block is Celgene Corporation (NASDAQ: CELG).
Celgene has a market capitalization of $98 billion.
The second-largest biotech stock by market cap is Amgen, Inc. (NASDAQ: AMGN).
With a market cap of $120 billion, Amgen is still a distance from the largest biotech of them all.
The biggest biotech is Gilead Sciences, Inc. (NASDAQ: GILD).
Gilead is bigger than both Biogen and Regeneron put together with a market cap of over $155 billion.
All five stocks closed up in the green on Tuesday.
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Excerpt from –